Cargando…

HDAC Inhibition Decreases the Expression of EGFR in Colorectal Cancer Cells

Epidermal growth factor receptor (EGFR), a receptor tyrosine kinase which promotes cell proliferation and survival, is abnormally overexpressed in numerous tumors of epithelial origin, including colorectal cancer (CRC). EGFR monoclonal antibodies have been shown to increase the median survival and a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chou, Chia-Wei, Wu, Ming-Shiang, Huang, Wei-Chien, Chen, Ching-Chow
Formato:	Texto
Lenguaje:	English
Publicado:	Public Library of Science 2011
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3064594/ https://www.ncbi.nlm.nih.gov/pubmed/21464950 http://dx.doi.org/10.1371/journal.pone.0018087

Ejemplares similares

Induction of c-Cbl contributes to anti-cancer effects of HDAC inhibitor in lung cancer
por: Wei, Tzu-Tang, et al.
Publicado: (2015)

Trichostatin A Suppresses EGFR Expression through Induction of MicroRNA-7 in an HDAC-Independent Manner in Lapatinib-Treated Cells
por: Tu, Chih-Yen, et al.
Publicado: (2014)

Zebularine inhibits tumorigenesis and stemness of colorectal cancer via p53-dependent endoplasmic reticulum stress
por: Yang, Pei-Ming, et al.
Publicado: (2013)

HDAC1 and HDAC2 Double Knockout Triggers Cell Apoptosis in Advanced Thyroid Cancer
por: Lin, Ching-Ling, et al.
Publicado: (2019)

Inhibition of HDAC3- and HDAC6-Promoted Survivin Expression Plays an Important Role in SAHA-Induced Autophagy and Viability Reduction in Breast Cancer Cells
por: Lee, Jane Ying-Chieh, et al.
Publicado: (2016)

The prognostic values of EGFR expression and KRAS mutation in patients with synchronous or metachronous metastatic colorectal cancer
por: Huang, Ching-Wen, et al.
Publicado: (2013)

Inhibition of HDAC1 and DNMT1 Modulate RGS10 Expression and Decrease Ovarian Cancer Chemoresistance
por: Cacan, Ercan, et al.
Publicado: (2014)

YY1 promotes HDAC1 expression and decreases sensitivity of hepatocellular carcinoma cells to HDAC inhibitor
por: Dong, Sheng, et al.
Publicado: (2017)

Higher nuclear EGFR expression is a better predictor of survival in rectal cancer patients following neoadjuvant chemoradiotherapy than cytoplasmic EGFR expression
por: Yang, Ching-Chieh, et al.
Publicado: (2019)

HDAC2 inhibits EMT-mediated cancer metastasis by downregulating the long noncoding RNA H19 in colorectal cancer
por: Hu, Xue-ting, et al.
Publicado: (2020)

EGFR phosphorylates HDAC1 to regulate its expression and anti-apoptotic function
por: Bahl, Sonali, et al.
Publicado: (2021)

EGFR expression in patients with stage III colorectal cancer after adjuvant chemotherapy and on cancer cell function
por: Huang, Ching-Wen, et al.
Publicado: (2017)

Histone deacetylase (HDAC) 11 inhibits matrix metalloproteinase (MMP) 3 expression to suppress colorectal cancer metastasis
por: Wen, Yuqing, et al.
Publicado: (2022)

The Emergent Landscape of Detecting EGFR Mutations Using Circulating Tumor DNA in Lung Cancer
por: Huang, Wei-Lun, et al.
Publicado: (2015)

Selective inhibition of HDAC6 promotes bladder cancer radiosensitization and mitigates the radiation-induced CXCL1 signalling
por: Tsai, Yu-Chieh, et al.
Publicado: (2023)

Dynamic changes in quality of life after three first-line therapies for EGFR mutation-positive advanced non-small-cell lung cancer
por: Yang, Szu-Chun, et al.
Publicado: (2018)

Prediction of response to anti-EGFR antibodies in metastatic colorectal cancer: looking beyond EGFR inhibition
por: Ottaiano, Alessandro, et al.
Publicado: (2013)

MiR-320d Inhibits Progression of EGFR-Positive Colorectal Cancer by Targeting TUSC3
por: Yufeng, Zhu, et al.
Publicado: (2021)

Maintenance of HDACs and H3K9me3 Prevents Arterial Flow-Induced Venous Endothelial Damage
por: Wang, Ting-Yun, et al.
Publicado: (2021)

Aspirin Prevents Colorectal Cancer by Normalizing EGFR Expression
por: Li, Haitao, et al.
Publicado: (2015)

Elevated BCRP/ABCG2 Expression Confers Acquired Resistance to Gefitinib in Wild-Type EGFR-Expressing Cells
por: Chen, Yun-Ju, et al.
Publicado: (2011)

GPR126 regulates colorectal cancer cell proliferation by mediating HDAC2 and GLI2 expression
por: Cui, Hengxiang, et al.
Publicado: (2021)

Clinical implications of PNA‑sequencing as a complementary test for EGFR mutation analysis in human lung cancer
por: Chen, Yi-Lin, et al.
Publicado: (2023)

Outreach and Inreach Organized Service Screening Programs for Colorectal Cancer
por: Chou, Chu-Kuang, et al.
Publicado: (2016)

UHRF1 depletion and HDAC inhibition reactivate epigenetically silenced genes in colorectal cancer cells
por: Niinuma, Takeshi, et al.
Publicado: (2019)

Non-epigenetic function of HDAC8 in regulating breast cancer stem cells by maintaining Notch1 protein stability
por: Chao, Min-Wu, et al.
Publicado: (2015)

Dual inhibition of HDAC and EGFR signaling with CUDC-101 induces potent suppression of tumor growth and metastasis in anaplastic thyroid cancer
por: Zhang, Lisa, et al.
Publicado: (2015)

Combinational inhibition of EGFR and YAP reverses 5-Fu resistance in colorectal cancer
por: Huang, Changhao, et al.
Publicado: (2020)

Improved survival in patients with unresectable stage III EGFR ‐mutant adenocarcinoma with upfront EGFR‐tyrosine kinase inhibitors
por: Wang, Sheng‐Yuan, et al.
Publicado: (2021)

Anticancer Activity and Mechanisms of Action of New Chimeric EGFR/HDAC-Inhibitors
por: Goehringer, Nils, et al.
Publicado: (2021)

Tp53 haploinsufficiency is involved in hotspot mutations and cytoskeletal remodeling in gefitinib-induced drug-resistant EGFR(L858R)-lung cancer mice
por: Wang, Yi-Shiang, et al.
Publicado: (2023)

Retraction: Non-epigenetic function of HDAC8 in regulating breast cancer stem cells by maintaining Notch1 protein stability
por: Chao, Min-Wu, et al.
Publicado: (2020)

HDAC Inhibition Regulates Cardiac Function by Increasing Myofilament Calcium Sensitivity and Decreasing Diastolic Tension
por: Eaton, Deborah M., et al.
Publicado: (2022)

Dual EGFR inhibition in combination with anti-VEGF treatment in colorectal cancer
por: Falchook, Gerald S., et al.
Publicado: (2014)

Valproic Acid and Other HDAC Inhibitors Upregulate FGF21 Gene Expression and Promote Process Elongation in Glia by Inhibiting HDAC2 and 3
por: Leng, Yan, et al.
Publicado: (2016)

Licochalcone A inhibits EGFR signalling and translationally suppresses survivin expression in human cancer cells
por: Gao, Feng, et al.
Publicado: (2020)

Impact of the 3D Microenvironment on Phenotype, Gene Expression, and EGFR Inhibition of Colorectal Cancer Cell Lines
por: Luca, Anna C., et al.
Publicado: (2013)

HDAC9 promotes glioblastoma growth via TAZ-mediated EGFR pathway activation
por: Yang, Rui, et al.
Publicado: (2015)

EGFR–c-Src-Mediated HDAC3 Phosphorylation Exacerbates Invasion of Breast Cancer Cells
por: Kwak, Sung-Min, et al.
Publicado: (2019)

HDAC6 promotes aggressive development of liver cancer by improving egfr mRNA stability
por: Dai, Hong-Ying, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_eqoedfa7gkhpefe1uva7noutgl